LV10777B - A process for preparing of chemical compounds, composition thereof, a method of combatting infections or infestations - Google Patents
A process for preparing of chemical compounds, composition thereof, a method of combatting infections or infestations Download PDFInfo
- Publication number
- LV10777B LV10777B LVP-93-372A LV930372A LV10777B LV 10777 B LV10777 B LV 10777B LV 930372 A LV930372 A LV 930372A LV 10777 B LV10777 B LV 10777B
- Authority
- LV
- Latvia
- Prior art keywords
- compound
- hydroxy
- hydrogen
- group
- ηλη
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/238—Cyclohexane rings substituted by two guanidine radicals, e.g. streptomycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858510943A GB8510943D0 (en) | 1985-04-30 | 1985-04-30 | Chemical compounds |
GB858510944A GB8510944D0 (en) | 1985-04-30 | 1985-04-30 | Chemical compounds |
GB858510942A GB8510942D0 (en) | 1985-04-30 | 1985-04-30 | Chemical compounds |
GB868606103A GB8606103D0 (en) | 1986-03-12 | 1986-03-12 | Chemical compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
LV10777A LV10777A (lv) | 1995-08-20 |
LV10777B true LV10777B (en) | 1996-04-20 |
Family
ID=27449656
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-93-372A LV10777B (en) | 1985-04-30 | 1993-05-18 | A process for preparing of chemical compounds, composition thereof, a method of combatting infections or infestations |
LVP-93-1406A LV10314B (en) | 1985-04-30 | 1993-12-31 | Process for preparation of macrolides |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-93-1406A LV10314B (en) | 1985-04-30 | 1993-12-31 | Process for preparation of macrolides |
Country Status (25)
Country | Link |
---|---|
US (1) | US4978675A (es) |
JP (1) | JPH0819132B2 (es) |
KR (1) | KR930011282B1 (es) |
AT (1) | AT397095B (es) |
AU (1) | AU596586B2 (es) |
BE (1) | BE904709A (es) |
CA (1) | CA1335368C (es) |
CH (1) | CH675124A5 (es) |
DE (1) | DE3614549C2 (es) |
DK (1) | DK160992C (es) |
ES (4) | ES8802229A1 (es) |
FR (1) | FR2587344B1 (es) |
GB (1) | GB2176182B (es) |
GE (3) | GEP19971046B (es) |
HU (1) | HU200771B (es) |
IE (1) | IE59070B1 (es) |
IL (1) | IL78621A (es) |
LU (1) | LU86412A1 (es) |
LV (2) | LV10777B (es) |
NL (1) | NL193420C (es) |
NZ (1) | NZ215997A (es) |
PH (1) | PH23386A (es) |
PT (1) | PT82485B (es) |
RU (1) | RU2004545C1 (es) |
SE (1) | SE503571C2 (es) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT396250B (de) * | 1984-09-14 | 1993-07-26 | American Cyanamid Co | Verfahren zur herstellung von neuen antibiotisch wirkenden verbindungen |
ES8800986A1 (es) * | 1985-07-27 | 1987-12-01 | Pfizer | Un procedimiento para la produccion de un nuevo derivado de avermectina |
IE67373B1 (en) * | 1985-09-13 | 1996-03-20 | American Cyanamid Co | Macrolide antibiotics and their preparation |
US5185456A (en) * | 1986-03-12 | 1993-02-09 | American Cyanamid Company | Macrolide compounds |
GB8606108D0 (en) * | 1986-03-12 | 1986-04-16 | Glaxo Group Ltd | Chemical compounds |
US5336789A (en) * | 1986-03-12 | 1994-08-09 | American Cyanamid Company | Macrolide compounds |
ES2059366T3 (es) * | 1986-03-12 | 1994-11-16 | American Cyanamid Co | Compuestos macrolidos. |
GB8606123D0 (en) * | 1986-03-12 | 1986-04-16 | Glaxo Group Ltd | Chemical compounds |
AU609032B2 (en) * | 1986-03-12 | 1991-04-26 | American Cyanamid Company | Macrolide compounds |
BR8701118A (pt) * | 1986-03-12 | 1988-01-05 | Glaxo Group Ltd | Processo para a preparacao de um composto quimico,processo para combater pestes em agricultura,horicultura ou silvicultura,ou em lojas,predios e outros locais publicos e composicao de controle de pestes |
GB8613790D0 (en) * | 1986-06-06 | 1986-07-09 | Glaxo Group Ltd | Chemical compounds |
CA1296329C (en) * | 1986-06-06 | 1992-02-25 | Derek R. Sutherland | Macrolide compounds |
US5840704A (en) * | 1986-07-16 | 1998-11-24 | Pfizer Inc. | Antiparasitic agents and process for their preparation |
DE3750495T2 (de) * | 1986-07-24 | 1995-02-23 | Beecham Group Plc | Milbemycin-Derivate mit parasitenabtötender Aktivität, ein Verfahren zu ihrer Herstellung und die sie enthaltenden Zusammensetzungen. |
EP0260537A1 (en) * | 1986-09-12 | 1988-03-23 | American Cyanamid Company | 13-Deoxy-23-oxo(keto) and 23-imino derivatives of 13-deoxy C-076-aglycone compounds |
ES2055695T3 (es) * | 1986-09-12 | 1994-09-01 | American Cyanamid Co | Derivados 23-desoxi de compuestos ll-f28249. |
EP0259779B1 (en) * | 1986-09-12 | 1994-08-10 | American Cyanamid Company | 23-Oxo (Keto) and 23-imino Derivatives of LL-F28249 Compounds |
US5149832A (en) * | 1986-09-12 | 1992-09-22 | American Cyanamid Company | Mono and diacyl derivatives of ll-f28249 compounds |
US4916154A (en) * | 1986-09-12 | 1990-04-10 | American Cyanamid Company | 23-Imino derivatives of LL-F28249 compounds |
US5525506A (en) * | 1987-01-23 | 1996-06-11 | Pfizer Inc. | Process for production of avermectins and cultures therefor |
US5234831A (en) * | 1987-01-23 | 1993-08-10 | Pfizer Inc | Cultures for production of B avermectins |
US5238848A (en) * | 1987-01-23 | 1993-08-24 | Pfizer Inc | Cultures for production of avermectins |
US4886830A (en) * | 1987-03-06 | 1989-12-12 | American Cyanamid Company | Mono- and diepoxide derivatives of 23-deoxyl-LL-F28249 compounds |
US4956479A (en) * | 1987-03-06 | 1990-09-11 | American Cyanamid Company | 23-deoxy-27-chloro derivatives of LL-F28249 compounds |
US4886829A (en) * | 1987-03-06 | 1989-12-12 | American Cyanamid Company | 23-Oxo (keto) and 23-imino derivatives of mono- and diepoxy LL-F28249 compounds |
US4806527A (en) * | 1987-03-16 | 1989-02-21 | Merck & Co., Inc. | Avermectin derivatives |
US4871719A (en) * | 1987-03-24 | 1989-10-03 | Ciba-Geigy Corporation | Composition for controlling parasites in productive livestock |
EP0285561A3 (de) * | 1987-03-27 | 1989-10-25 | Ciba-Geigy Ag | Parasitizide und insektizide Milbemycin-Derivate |
JPS6431776A (en) * | 1987-07-28 | 1989-02-02 | Sankyo Co | Novel macrolide compound and production thereof |
PT88465B (pt) * | 1987-09-11 | 1992-11-30 | American Cyanamid Co | Processo para a preparacao de um composto macrolido |
GB8721377D0 (en) * | 1987-09-11 | 1987-10-21 | Glaxo Group Ltd | Chemical compounds |
GB8721378D0 (en) * | 1987-09-11 | 1987-10-21 | Glaxo Group Ltd | Chemical process |
GB8721373D0 (en) * | 1987-09-11 | 1987-10-21 | Glaxo Group Ltd | Chemical process |
GB8721375D0 (en) * | 1987-09-11 | 1987-10-21 | Glaxo Group Ltd | Chemical process |
GB8721376D0 (en) * | 1987-09-11 | 1987-10-21 | Glaxo Group Ltd | Chemical compounds |
GB8721647D0 (en) * | 1987-09-15 | 1987-10-21 | Pfizer Ltd | Antiparasitic agents |
US5240850A (en) * | 1987-10-23 | 1993-08-31 | Pfizer Inc. | Cultures for production of avermectin aglycones |
ES2045146T3 (es) * | 1987-11-09 | 1994-01-16 | Pfizer | Avermectinas etiladas. |
GB8726384D0 (en) * | 1987-11-11 | 1987-12-16 | Coopers Animal Health | Veterinary treatment |
GB8726730D0 (en) * | 1987-11-14 | 1987-12-16 | Pfizer Ltd | Antiparasitic agents |
GB8801908D0 (en) * | 1988-01-28 | 1988-02-24 | Glaxo Group Ltd | Chemical compounds |
GB8804440D0 (en) * | 1988-02-25 | 1988-03-23 | Pfizer Ltd | Antiparasitic agents |
GB8811036D0 (en) * | 1988-05-10 | 1988-06-15 | Glaxo Group Ltd | Chemical compounds |
JP2629047B2 (ja) * | 1988-05-10 | 1997-07-09 | アメリカン・サイアナミツド・カンパニー | マクロライド化合物 |
GB8811037D0 (en) * | 1988-05-10 | 1988-06-15 | Glaxo Group Ltd | Chemical compounds |
GB8813150D0 (en) * | 1988-06-03 | 1988-07-06 | American Cyanamid Co | Chemical compounds |
GB8813760D0 (en) * | 1988-06-10 | 1988-07-13 | American Cyanamid Co | Chemical process |
US5428034A (en) * | 1988-09-02 | 1995-06-27 | Sankyo Co., Ltd. | Milbemycin derivatives, their preparation and their use |
US6001822A (en) * | 1989-04-11 | 1999-12-14 | Pfizer Inc. | Antiparasitic formulations |
DK0393890T3 (da) * | 1989-04-11 | 1992-09-28 | Pfizer | Injicerbart præparat indeholdende 25-cyclohexyl-avermectin B1 |
NZ234802A (en) * | 1989-08-14 | 1992-11-25 | Merck & Co Inc | Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals |
US5055486A (en) * | 1989-12-22 | 1991-10-08 | American Cyanamid Company | 13-alkyl-23-imino derivative of LL-F28249 compounds and their use as endo- and ectoparasiticidal, insecticidal, acaricidal and nematocidal agents |
US4988824A (en) * | 1989-09-11 | 1991-01-29 | Maulding Donald R | Process for the preparation of 23-(C1-C6 alkyloxime)-LL-F28249 compounds |
JP2622197B2 (ja) * | 1990-03-01 | 1997-06-18 | 三共株式会社 | 13−エーテル置換ミルベマイシン誘導体 |
US5290804A (en) * | 1991-05-01 | 1994-03-01 | Merck & Co., Inc. | Anthelmintic milbemycin analogs of novel microorganisms |
DK0535734T3 (da) * | 1991-09-30 | 1999-08-09 | Merck & Co Inc | Langtidsvirkende injicerbare formuleringer indeholdende hydrogeneret castorolie |
US6103504A (en) * | 1992-03-25 | 2000-08-15 | Pfizer Inc. | Process for production of avermectins and cultures therefor |
DE19534366C2 (de) * | 1995-09-15 | 2000-08-17 | Asta Medica Ag | Verfahren zur Herstellung von 2,3,4,6-Tetra-O-benzyl-D-glucopyranose und 2,3,4,6-Tetra-O-allyl-D-glucopyranose |
CA2211949A1 (en) * | 1997-07-21 | 1999-01-29 | David Farley Johnson | Nonaqueous compositions for parenteral administration |
PT1197215E (pt) | 2000-10-10 | 2006-07-31 | Wyeth Corp | Composicoes antelminticas |
NZ552040A (en) * | 2006-12-13 | 2009-04-30 | Bomac Research Ltd | Veterinary formulation comprising an anthelmintic compound and glyceryl acetate |
DE102010064245A1 (de) | 2010-12-28 | 2012-06-28 | Bayer Animal Health Gmbh | Makrocylischen Lactone und deren Verwendung und deren Kombinationen mit anderen Wirkstoffen |
WO2012028556A1 (en) | 2010-08-31 | 2012-03-08 | Bayer Animal Health Gmbh | Macrocyclic lactones and their use and their combinations with other active substances |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4201861A (en) * | 1977-10-03 | 1980-05-06 | Merck & Co., Inc. | Acyl derivatives of C-076 compounds |
US4550160A (en) * | 1979-08-13 | 1985-10-29 | Merck & Co., Inc. | Processes for the interconversion of C-076 compounds |
JPS5632481A (en) * | 1979-08-23 | 1981-04-01 | Sankyo Co Ltd | Antibiotic b-41d, its preparation, and acaricide and anthelminthic agent and repellent containing the same as active constituent |
US4289760A (en) * | 1980-05-02 | 1981-09-15 | Merck & Co., Inc. | 23-Keto derivatives of C-076 compounds |
US4457920A (en) * | 1981-09-03 | 1984-07-03 | Merck & Co., Inc. | 4a-Substituted avermectin compounds |
US4423209A (en) * | 1982-02-26 | 1983-12-27 | Merck & Co., Inc. | Processes for the interconversion of avermectin compounds |
JPS59108785A (ja) * | 1982-11-25 | 1984-06-23 | Sankyo Co Ltd | ミルベマイシン類の5−オキシム誘導体 |
JPS60126289A (ja) * | 1983-11-14 | 1985-07-05 | Sankyo Co Ltd | ミルベマイシン類の5−カ−ボネ−ト誘導体 |
PT80577B (pt) * | 1984-06-05 | 1987-09-18 | American Cyanamid Co | Processo para a producao de novos agentes macrolidos ll-f28249 uteis no tratamento de infeccoes helminticas por ectoparasitas artropodes e por acarideos |
AT396250B (de) * | 1984-09-14 | 1993-07-26 | American Cyanamid Co | Verfahren zur herstellung von neuen antibiotisch wirkenden verbindungen |
ES8800986A1 (es) * | 1985-07-27 | 1987-12-01 | Pfizer | Un procedimiento para la produccion de un nuevo derivado de avermectina |
-
1986
- 1986-04-28 AU AU56767/86A patent/AU596586B2/en not_active Ceased
- 1986-04-28 ES ES554444A patent/ES8802229A1/es not_active Expired
- 1986-04-28 IL IL78621A patent/IL78621A/xx not_active IP Right Cessation
- 1986-04-29 DK DK196586A patent/DK160992C/da not_active IP Right Cessation
- 1986-04-29 RU SU864027456A patent/RU2004545C1/ru active
- 1986-04-29 KR KR1019860003297A patent/KR930011282B1/ko not_active IP Right Cessation
- 1986-04-29 CH CH1749/86A patent/CH675124A5/de not_active IP Right Cessation
- 1986-04-29 SE SE8601998A patent/SE503571C2/sv not_active IP Right Cessation
- 1986-04-29 DE DE3614549A patent/DE3614549C2/de not_active Expired - Fee Related
- 1986-04-29 NL NL8601103A patent/NL193420C/nl not_active IP Right Cessation
- 1986-04-29 IE IE112786A patent/IE59070B1/en not_active IP Right Cessation
- 1986-04-29 CA CA000507815A patent/CA1335368C/en not_active Expired - Fee Related
- 1986-04-29 AT AT0115486A patent/AT397095B/de not_active IP Right Cessation
- 1986-04-29 LU LU86412A patent/LU86412A1/fr unknown
- 1986-04-29 NZ NZ215997A patent/NZ215997A/xx unknown
- 1986-04-30 PT PT82485A patent/PT82485B/pt not_active IP Right Cessation
- 1986-04-30 GB GB08610631A patent/GB2176182B/en not_active Expired
- 1986-04-30 PH PH33722A patent/PH23386A/en unknown
- 1986-04-30 HU HU861816A patent/HU200771B/hu not_active IP Right Cessation
- 1986-04-30 FR FR868606345A patent/FR2587344B1/fr not_active Expired - Fee Related
- 1986-04-30 BE BE0/216612A patent/BE904709A/fr not_active IP Right Cessation
- 1986-04-30 JP JP61098435A patent/JPH0819132B2/ja not_active Expired - Fee Related
-
1987
- 1987-04-30 ES ES557517A patent/ES8802522A1/es not_active Expired
- 1987-10-30 ES ES557774A patent/ES8900093A1/es not_active Expired
- 1987-11-10 US US07/119,347 patent/US4978675A/en not_active Expired - Lifetime
-
1988
- 1988-09-01 ES ES557851A patent/ES9000023A1/es not_active Expired
-
1993
- 1993-05-18 LV LVP-93-372A patent/LV10777B/lv unknown
- 1993-07-16 GE GEAP19931052A patent/GEP19971046B/en unknown
- 1993-12-31 LV LVP-93-1406A patent/LV10314B/lv unknown
-
1994
- 1994-12-29 GE GEAP19942319A patent/GEP19970833B/en unknown
-
1997
- 1997-02-07 GE GEAP19973574A patent/GEP20001917B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV10777B (en) | A process for preparing of chemical compounds, composition thereof, a method of combatting infections or infestations | |
Tanaka et al. | Agroactive compounds of microbial origin | |
Wehrli et al. | Actions of the rifamycins | |
Şahin et al. | Investigation of the antimicrobial activity of some Streptomyces isolates | |
Shoop et al. | Structure and activity of avermectins and milbemycins in animal health | |
US5262400A (en) | 4α-substituted avermectin derivatives | |
PT1489082E (pt) | Compostos intermediários | |
JPS63119486A (ja) | Ll−f28249化合物の23−オキソ(ケト)および23−イミノ誘導体 | |
Li et al. | Staurosporine from the endophytic Streptomyces sp. strain CNS-42 acts as a potential biocontrol agent and growth elicitor in cucumber | |
Li et al. | Polyene-producing Streptomyces spp. from the fungus-growing termite Macrotermes barneyi exhibit high inhibitory activity against the antagonistic fungus Xylaria | |
CN106496203B (zh) | 一种喹啉酮类化合物的制备方法与作为抗单纯疱疹ⅰ型病毒剂的应用 | |
US4987072A (en) | Macrocyclic antibiotics | |
DE2627076A1 (de) | Mittel zur inhibierung des zellwachstums | |
US5229416A (en) | Avermectin difluoro derivatives | |
EP1986651B1 (en) | Use of a pyrimidinedione derivative for preventing or treating hepatitis c | |
EP0345078B1 (en) | Macrolide compounds | |
US5116968A (en) | Macrolide compounds | |
Sedjoah et al. | Overexpression of PPtase in Streptomyces sp. NAUS: Increasing biocontrol potential against postharvest tomato fruit decay and isolation of a novel antifungal compound | |
Pankiewicz et al. | NAD analogs. 1. Synthesis of isosteric analogs of nicotinamide adenine dinucleotide containing C-nucleotide of nicotinamide or picolinamide | |
Shkarupeta et al. | Analysis of antibiotic resistance markers in Chlamydia trachomatis clinical isolates obtained after ineffective antibiotic therapy | |
Spero et al. | Chlorate specifically targets oxidantstarved, antibiotic-tolerant populations of Pseudomonas aeruginosa biofilms. mBio 9: e01400-18 | |
SUN et al. | Effects of soil enzyme activity and bacterial community under different crop rotations | |
Dame et al. | Production of macrolide antibiotics from a cytotoxic soil Streptomyces sp. strain ZDB | |
EP0242052B1 (en) | Macrolide compounds | |
Jeon et al. | Pentaene macrolides AB023a and takanawaene C produced by Streptomyces xanthocidicus strain S3 for controlling pepper anthracnose |